News
Sports
Entertainment
Log In
My Page
Help
NEWS SEARCH ANALYSIS INSIGHT
360° Search
Network
Hot Spots
Trends
Advanced Search Options >>
Advanced Search Options
Here you can filter your search on content type, content source and/or a date range. Any search result can be bookmarked to maintain the filter for future use.
Select Content Types:
News
Reports
Blogs
Audio/Video
Fact Sheets
Select Content Sources:
Select one or several content sources by entering the name of a publication or source in the text box. Select the source from the list of suggestions and click the 'Add' button. Repeat to add several sources to your filter.
Select Date Range:
Input an optional from and/or to date to limit the search to a date-range.
From Date:
MM/DD/YYYY
To Date:
MM/DD/YYYY
Sunday, March 21, 2010 1:42 PM
Give Feedback
Identify Entity
Request Content
Home
Global Issues
Technology
Science
Business
Energy
World
Global Issues - Home
Politics
Conflicts & Crime
Environment
Health
Health - Home
Diseases
Epidemics
Medical Treatment
Medication
Nutrition & Diet
Water & Food Safety
MacDougall Biomedical Communications
Type:
Company
Name:
MacDougall Biomedical Communications
Quotes
"
IMO-2125, an Agonist of TLR9 that Induces Endogenous IFN-a, Upregulates Broader Range of Gene Expression Profiles Compared to Exogenously Added IFN -a in Human PBMCs
"
; Friday, April 16, 2010
Idera Pharmaceuticals Announces Acceptance of IMO-2125 Abstracts for Presentation at EASL Annual ... [FinanzNachrichten.de - Mar 17 2010]
Charles Nicolette, Ph D , Chief Scientific Officer and Vice President of ResearchResearch and DevelopmentDevelopment of Argos Therapeutics, added,
"
We are excited about the Arcelis immunotherapy platform because it is so well suited to the pathology of HIV infection; it overcomes the viral variability and the immune suppressive mechanisms that allow the virus to persist chronically and, remarkably, this is achieved without activation of CD4+ T cells, which are known to serve as factories for viral replication. This current study confirms previous proof-of-concept studies that have shown that our approach is able to induce a diverse immune response to HIV in patients.
"
Argos Therapeutics Publishes Positive Immune Response, Safety and Manufacturing Data for its Arce ... [AEGIS - Mar 06 2010]
More Content
All (3)
|
News (3)
|
Reports (0)
|
Blogs (0)
|
Audio/Video (0)
|
Fact Sheets (0)
sort by:
Date
|
Relevance
Idera Pharmaceuticals Announces Acceptance of I...
[FinanzNachrichten.de - Mar 17 2010]
Argos Therapeutics Publishes Positive Immune Re...
[AEGIS - Mar 06 2010]
Idera Pharmaceuticals Presents Mechanism of Act...
[FinanzNachrichten.de - Feb 23 2010]
1
In Focus
Jean-Pierre Routy
,
Tim Sullivan
Idera Pharmaceuticals Inc
,
Argos Therapeutics Inc
,
Argos
,
[more]
TM Technology Inc.
McGill University
Merck KGaA
Merck & Co Inc
American Association for the Study of ...
,
Food and Drug Administration
,
Elton John Aids Foundation
,
[more]
National Institute of Allergy and Inf ...
United States Department of Health an ...
National institutes of Health
HIV/AIDS
,
Clinical Immunology
,
Receptor
,
[more]
agonist
cytokine
Immunotherapy
Immune System
autologous
immune response
Antigen
RNA
T Cell
Clinical Trials
Cancer
Hepatitis C Virus
Argos (United States)
,
Vienna
,
Taos (New Mexico, United States)
,
[more]
Montreal
United States
,
Austria
Medication
,
Biology
,
Medicine
,
[more]
Biotechnology
Research & Development
Diseases
Epidemics
Pharma & Biotech
,
Logistics & Shipping
FinanzNachrichten.de
,
AEGIS
Content Volume
Network
Products & Services
Silobreaker.com
Enterprise Online Service
Enterprise Software Suite
Widgets & API
How To Use
Silobreaker
RSS
API
Widgets
Advertise With Us
Advertise
Follow Us
Press Room
Blog
YouTube
Twitter
About Us
About Silobreaker
Background and History
Why Silobreaker?
Value Proposition
Technology
Team
Contact Us
Legal
Terms of Use
Privacy Policy
Some image thumbnails are sourced from
Freebase
, licensed under
CC-BY
Copyright (C) 2009 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.